www.stirlingproducts.net
Stirling Products (ASX:STI) is a manufacturer and marketer of proprietary and/or patented pharmaceutical products and natural health products for its own interests as well as on a contractual basis for third parties. Strategically, Stirling Products is positioned to capitalise on the rapidly changing conditions within the global pharmaceutical and health markets.
The Stirling Products corporate headquarters are in Sydney, Australia and its North American pharmaceutical manufacturing operations are based on Cape Breton, Nova Scotia, Canada.
Stirling operates through three main business units each managed by proven industry specialist managers:
- Pharmaceutical & Healthcare
- Research & Development
- Animal Products
Stirling Products' TeleMedCare devices trialled by Boots Pharmacy
Stirling Products (ASX:STI) has revealed that Boots Pharmacy is the major pharmacy group involved in a pilot trial of the TeleMedCare e-health vital sign monitoring devices in the United Kingdom.
Boots is the UK’s leading pharmacy with 2,500 outlets throughout the UK and a member of Alliance Boots, an international pharmacy, health and beauty group.
Although the company did not disclose the detail of the pharmacy chain at the time of the information release to the market, the UK publication Chemist and Druggist in its current edition has published that it had confirmation that it was Boots taking part in the trial.


















